Skip to main content

Advertisement

Fig. 1 | Experimental Hematology & Oncology

Fig. 1

From: Autoimmune rhabdomyolysis and a multiorgan display of PD-1 inhibitor induced immune related adverse events during treatment of metastatic melanoma

Fig. 1

a Decline in AST/ALT levels following initiation of steroid therapy (orange arrow). b Correction of hyperthyroid state with decline in free T4 and recovery of TSH following initiation of steroid therapy (orange arrow). c Decline in CK following initiation of steroid therapy (orange arrow). C1D1, cycle 1 day 1; C2D15, cycle 2 day 15; HD, hospital day

Back to article page